Kerala decides to treat haemophilia patients with Emicizumab

Hemophilia — also known as the royal disease — is a usually inherited bleeding disorder that prevents the blood from clotting properly.

BySouth First Desk

Published Jul 27, 2024 | 1:00 PMUpdatedJul 27, 2024 | 1:00 PM

Haemophilia

The Kerala government decided to use the drug Emicizumab to treat all children below the age of 18 having haemophilia. Around 300 children are expected to benefit from this. Emicizumab is a medication used to prevent bleeding episodes in people with haemophilia. It’s a bio-specific antibody that helps blood to clot normally, reducing the risk of bleeding complications.

Read the full story here